Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments Forbes Prior to the FDA action, patients were required to get an infusion of rituximab the first day, followed by a pre-treatment diagnostic dose of radiolabeled indium-111 Zevalin.Then the patient gets a full-body gamma scan at a nuclear imaging center ... |
